bioRxivCell Biology
Increased autophagy in ephrinB2 deficient osteocytes is associated with hypermineralized, brittle bones
C. Vrahnas, T. A. Dite, N. Ansari, B. Crimeen-Irwin, H. Nguyen, M. R. Forwood, Y. Hu, M. Ikegame, K. R. Bambery, C. Petibois, M. J. Tobin, G. K. Smyth, J. S. Oakhill, T. J. Martin, N. A. Sims
Abstract
Mineralized bone forms when collagen-containing osteoid accrues hydroxyapatite crystals. This process has two phases: a rapid initiation (primary mineralization), followed by slower accrual of mineral (secondary mineralization) that continues until that portion of bone is renewed by remodelling. Within the bone matrix is an interconnected network of cells termed osteocytes. These cells are derived from bone-forming osteoblasts. Osteoblast differentiation requires expression of ephrinB2, and we were intrigued about why ephrinB2 continues to be expressed in mature osteocytes. To determine its function in osteocytes, we developed an osteocyte-specific ephrinB2 null mouse and found they exhibited a brittle bone phenotype. This was not caused by a change in bone mass, but by an intrinsic defect in the strength of the bone material. Although the initiation of osteoid mineralization occurred at a normal rate, the process of secondary mineralization was accelerated in these mice. The maturing mineralized bone matrix incorporated mineral and carbonate more rapidly than controls, indicating that osteocytic ephrinB2 suppresses mineral accumulation in bone. No known regulators of mineralization were modified in the bone of these mice. However, RNA sequencing showed differential expression of a group of autophagy-associated genes, and increased autophagic flux was confirmed in ephrinB2 knockdown osteocytes. This indicates that the process of secondary mineralization in bone makes use of autophagic machinery in a manner that is limited by ephrinB2 in osteocytes, and that this process may be disrupted in conditions of bone fragility.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- EphB3 receptor negatively regulates osteogenesis in mice
M. R. Rodriguez-Sosa, D. Alfaro, … A. G. Zapata·bioRxiv·Jun 15, 2023
- Osteocyte death and bone overgrowth in mice lacking Fibroblast Growth Factor Receptors 1 and 2 in mature osteoblasts and osteocytes
Jennifer A. McKenzie, Craig R. Smith, … David M. Ornitz·Journal of Bone and Mineral ResearchPeer-reviewed·Jun 17, 2019
- Impaired mitochondrial stress signaling mediates bone loss in male mice in the absence of BNIP3.
Li Tian, Victoria Van Berlo, … Anyonya R. Guntur·bioRxiv·Apr 8, 2026
- CRISPR activation of Tfeb, a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength
Alicen James, James A. Hendrixson, … Melda Onal·JCI InsightPeer-reviewed·Jul 29, 2025
- Estrogen Deficiency alters Vascularization and Mineralization dynamics: insight from a novel 3D Humanized and Vascularized Bone Organoid Model
M. Bukhari, Mostafa Khabooshani, … Laoise M. McNamara·American Journal of Physiology-Cell PhysiologyPeer-reviewed·Jan 17, 2025
- Erythroferrone Modulates Osteoblast-Osteoclast Crosstalk During Bone Remodeling
Pinanong Na-Phatthalung, Gabrielle van Caloen, … Yelena Z. Ginzburg·bioRxiv·May 8, 2026